edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Speciality pharma company RedHill Biopharma focuses on gastrointestinal diseases and promotes several products in the US. It also has a rapidly progressing COVID-19 R&D programme investigating a therapeutic drug. The commercial portfolio includes Movantik (opioid-induced constipation), Talicia (H. pylori eradication) and Aemcolo (travellers’ diarrhoea). The most advanced R&D assets are RHB-204 for Nontuberculous Mycobacteria infections, RHB-104 for Crohn’s disease and Bekinda for gastroenteritis and IBS-D.
In this video, Guy Goldberg , chief business officer at RedHill, talks about its potential COVID-19 treatment opaganib and the business’s recent commercial progress.
Get access to the very latest content matched to your personal investment style.